Paolo Farneti/LinkedIn
Aug 11, 2025, 01:43
Delphi Consensus: A Safe Guide to Use of Sclerotherapy for Hereditary Hemorrhagic Telangiectasia-related Epistaxis
JAMA Otolaryngology – Head & Neck Surgery shared an insightful post on X:
”A Delphi consensus among six international experts established 30 statements to guide the safe and effective use of sclerotherapy for hereditary hemorrhagic telangiectasia (HHT)-related epistaxis.”
Read the full article here.
Article: Consensus on Sclerotherapy for Patients With Hereditary Hemorrhagic Telangiectasia–Related Epistaxis
Authors: Paolo Farneti, Sol Marcos-Salazar, Claudia Crocione,Holly Boyer, Roberto Puxeddu, Alan B. Whitehouse, Jay F. Piccirillo
Stay updated on the latest scientific advances in the field of bleeding disorders with Hemostasis Today.
-
Jul 6, 2026, 04:36Sarah Richardson: On Capitol Hill, Speaking Up for Patients
-
Jul 5, 2026, 23:26Nominations Now Open for the First Nations Stroke Excellence Award – Stroke Foundation
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation